Characterisation of T cells induced by candidate conserved region HIV-1 vaccines in healthy HIV-1/2 negative volunteers
<p>HIV-1 has claimed the lives of millions of people globally and continues to spread despite development of highly active antiretroviral therapy. In 2013, 2.1 million new infections occurred and over 35 million people were living with HIV-1 infection. A prophylactic HIV-1 vaccine that can pre...
Asıl Yazarlar: | Ahmed, T, Tina Ahmed |
---|---|
Diğer Yazarlar: | Hanke, T |
Materyal Türü: | Tez |
Dil: | English |
Baskı/Yayın Bilgisi: |
2014
|
Konular: |
Benzer Materyaller
-
The design and development of an HIV-1 vaccine to elicit a broadly neutralising antibody response
Yazar:: Wan, L, ve diğerleri
Baskı/Yayın Bilgisi: (2012) -
Architecture of the HIV-1 glycan shield
Yazar:: Pritchard, L
Baskı/Yayın Bilgisi: (2014) -
HIV-specific interleukin-10 responses and immune modulation
Yazar:: Clutton, G
Baskı/Yayın Bilgisi: (2012) -
Antibody-based HIV-1 vaccines: recent developments and future directions
Yazar:: Montefiori, D, ve diğerleri
Baskı/Yayın Bilgisi: (2007) -
T-cell receptor (TCR) usage in HIV-2 infection
Yazar:: Moysi, E
Baskı/Yayın Bilgisi: (2012)